Prospective Study
Copyright ©The Author(s) 2021.
World J Cardiol. Sep 26, 2021; 13(9): 503-513
Published online Sep 26, 2021. doi: 10.4330/wjc.v13.i9.503
Table 1 Baseline characteristics of the study population
Demographic/clinical
Age (mean ± SD, yr)77.50 ± 7.41
Female sex, n (%)94 (46)
Body weight (mean ± SD, kg)76.28 ± 14.22
Height (mean ± SD, m)1.66 ± 0.09
Systolic blood pressure (mmHg)135(34.8)
Diastolic blood pressure (mmHg)79 (21)
Heart rate (beats/minute)73.5 (19)
Left ventricular ejection fraction (%) (median, IQR)53.00 (37.50, 55.00)
Laboratory
RDW1 (mean ± SD)15.48% ± 2.15%
C-reactive protein2 (mg/L) (median, IQR)0.48 (0.16, 1.37)
Hemoglobin3 (mean ± SD, g/dL) 12.25 ± 1.92
Hematocrit3 (mean ± SD)37.89% ± 6.04%
White blood cells3 (K/μL)8.31 (2.85)
Urea (mg/dL) (median, IQR)51.70 (38.60, 70.50)
Creatinine3 (mean ± SD, mg/dL)1.21 (0.49)
SGOT4 (IU/L) (median, IQR)20.15 (16.55, 25.65)
SGPT4 (IU/L) (median, IQR)16.75 (11.65, 22.90)
K+4 (mean ± SD, mmol/L)4.20 ± 0.56
Na+1 (mmol/L) (median, IQR)140.00 (137.50, 142.00)
Non-cardiac conditions/morbidities, n (%)
Diabetes mellitus68 (33)
Chronic obstructive pulmonary disease37 (18)
Chronic kidney disease84 (41)
Sleep apnea15 (7)
Anemia85 (42)
Cardiac conditions/morbidities, n (%)
Acutely decompensated chronic heart failure104 (51)
Coronary artery disease133 (65)
Hypertension152 (75)
Atrial fibrillation97 (47.5)
Medications (discharge), n (%)
Renin-angiotensin-aldosterone system inhibitors159 (78)
Beta-blockers145 (71)
Diuretics137 (67)
Table 2 Results obtained from univariate linear regression analysis
Factor
Coefficient
95%CI
P value
Age0.072(0.033, 0.111)< 0.001
Sex (males vs females)-0.520(-1.115, 0.075)0.09
Weight -0.014(-0.035, 0.007)0.18
White blood cell count0.081(-0.024, 0.185)0.13
Urea 0.022(0.014, 0.030)< 0.001
C-reactive protein10.085(0.001, 0.169)0.05
Left ventricular ejection fraction-0.057(-0.073, -0.038)< 0.001
Acutely decompensated chronic heart failure2.220(1.708, 2.732)< 0.001
Coronary artery disease 0.039(-0.573, 0.650)0.9
Hypertension -0.519(-1.203, 0.165)0.14
Atrial fibrillation 1.862(1.322, 2.402)< 0.001
Diabetes mellitus 0.854(0.230, 1.477)0.01
Chronic obstructive pulmonary disease1.569(0.810, 2.327)< 0.001
Anemia 1.682(1.123, 2.242)< 0.001
Chronic kidney disease 1.590(1.022, 2.158)< 0.001
Sleep apnea1.448(0.289, 2.606)0.02
Table 3 Results obtained from the model selection procedure
Explanatory factors of RDW
Change in deviance1
P value
Models including 1 factor2
Age12.84< 0.001
Urea26.50< 0.001
C-reactive protein4.010.05
LVEF30.42< 0.001
ADCHF 62.86< 0.001
Atrial fibrillation 42.01< 0.001
Diabetes mellitus 7.230.007
COPD16.14< 0.001
Anemia 32.69< 0.001
CKD28.60< 0.001
Sleep apnea6.040.01
Models including 2 factors3
ADCHF + Age0.150.70
ADCHF + Urea3.030.08
ADCHF + C-reactive protein0.300.59
ADCHF + LVEF0.060.80
ADCHF + Atrial fibrillation19.33< 0.001
ADCHF + Diabetes mellitus3.080.08
ADCHF + COPD2.390.12
ADCHF + Anemia7.740.005
ADCHF + CKD0.850.36
ADCHF + Sleep apnea0.340.56
Models including 3 factors3
ADCHF + Atrial fibrillation + Age0.080.78
ADCHF + Atrial fibrillation + Urea2.100.15
ADCHF + Atrial fibrillation + C-reactive protein0.540.46
ADCHF + Atrial fibrillation + LVEF 0.750.39
ADCHF + Atrial fibrillation + Diabetes mellitus2.300.13
ADCHF + Atrial fibrillation + COPD0.890.35
ADCHF + Atrial fibrillation + Anemia8.350.004
ADCHF + Atrial fibrillation + CKD0.730.39
Models including 4 factors3
ADCHF + Atrial fibrillation + Anemia + Age0.500.48
ADCHF + Atrial fibrillation + Anemia + Urea1.160.28
ADCHF + Atrial fibrillation + Anemia + C-reactive protein0.340.56
ADCHF + Atrial fibrillation + Anemia + LVEF 1.860.17
ADCHF + Atrial fibrillation + Anemia + Diabetes mellitus0.920.34
ADCHF + Atrial fibrillation + Anemia + COPD0.770.38
ADCHF + Atrial fibrillation + Anemia + CKD0.260.61
Table 4 Results obtained from multivariate linear regression analysis
Factor
Coefficient
95%CI
P value
Acutely decompensated chronic heart failure1.406(0.830, 1.981)< 0.001
Atrial fibrillation1.192(0.673, 1.711)< 0.001
Anemia0.806(0.256, 1.355)0.004